腫瘍学におけるトポイソメラーゼII阻害剤:最新の特許レビュー (2016年現在)
Eleonora Turrini1, Francesca Maffei1, Andrea Milelli1
1Dipartimento di Scienze per la Qualità della Vita, Alma Mater Studiorum - Università di Bologna, Rimini, Italy.
Expert opinion on therapeutic patents
|September 7, 2025
まとめ
トポイソメラーゼII (topo II) を標的とする新型抗癌薬は有望であり,多くの新しい化合物が強い抗癌活性を示しています. しかし,臨床的な翻訳は,限られたin vivoデータのために課題です.
科学分野:
- 腫瘍学
- 薬剤化学
- 薬物の発見
背景:
- トポイソメラーゼII (トポII) 阻害剤は,がん治療において極めて重要です.
- 薬剤耐性および毒性によって臨床使用は制限されています.
研究 の 目的:
- 腫瘍学における新しいトーポII阻害剤に関する特許文献を分析する.
- 臨床前の進歩を評価し,臨床的翻訳のギャップを特定する.
主な方法:
- 2016年から2025年にかけての特許データベース (Espacenet,Wipo,Google Patent) の体系的なレビュー
- 合成化学,天然製品の分離,およびインシリコスクリーニングのアプローチの分析.
主要な成果:
- 強力な in vitro 細胞毒性を有する多種多様なトーポII 阻害剤の開発において,顕著な進展が見られた.
- トーポII毒に対する潜在的に安全な代替品としての触媒阻害剤の特定
- 臨床試験の進行は認められていない.
結論:
- 次世代のトーポII阻害剤は,有望な臨床前効果を示しています.
- 臨床開発を進めることは,イノベーションと翻訳のギャップを克服するために不可欠です.
- 将来の研究は in vivo 検証と臨床試験に重点を置くべきである.
関連する概念動画
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
DNA Topoisomerases
31.9K
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
31.9K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K


